(The author is a Reuters Breakingviews columnist. The opinions
expressed are her own.)
By Lauren Silva Laughlin
NEW YORK, Dec 15 (Reuters Breakingviews) -
O besity-fighting drugs should curb demand for hawkers of
weight-loss regimens. But WW bought a telehealth firm that can
push prescriptions, like those used by its celebrity backer, to
customers. As insurers fund habit-forming programs, companies
will find ways to take a cut.
Full view will be published shortly.
Follow @thereallsl on X
CONTEXT NEWS
WW International, formerly known as Weight Watchers, bought
Sequence, a digital health platform for clinical weight
management, in March 2023 for $132 million.
<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Graphic: Weight Watchers' valuation hasn't shared the Ozempic
bump https://tmsnrt.rs/3NqZABn
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
(Editing by Jonathan Guilford and Sharon Lam)
((For previous columns by the author, Reuters customers can
click on SILVA/
Lauren.SilvaLaughlin@thomsonreuters.com))